España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
LFTD Partners
LIFD
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.851200
0.25
41.87%
Pre-Market: May 20, 4:00 PM EDT
Get Report
Comment
LFTD Partners (LIFD) Forecast
News
Earnings
LFTD Partners (LIFD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for LFTD Partners (OTC:LIFD) Stock
LFTD Partners Stock (OTC: LIFD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
AP Reports Florida Voters Reject Cannabis Leg...
Benzinga Newsdesk
Wednesday, October 30, 2024
Microsoft shares are trading higher after the...
Benzinga Newsdesk
Wednesday, September 25, 2024
LIFD's 5x Potential: Is This Psychoactive Hemp Stock The Next Big Speculative Buy?
Nicolás Jose Rodriguez
Friday, August 25, 2023
Cannabis Stock Gainers And Losers From August 25, 2023
Benzinga Insights
Thursday, August 24, 2023
Cannabis Stock Gainers And Losers From August 24, 2023
Benzinga Insights
Wednesday, August 16, 2023
Cannabis Stock Gainers And Losers From August 16, 2023
Benzinga Insights
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
Monday, August 14, 2023
Cannabis Stock Gainers And Losers From August 14, 2023
Benzinga Insights
Tuesday, August 08, 2023
Marijuana Stock Movers For August 8, 2023
Benzinga Insights
Friday, August 04, 2023
Cannabis Stock Gainers And Losers From August 4, 2023
Benzinga Insights
Tuesday, August 01, 2023
Marijuana Stock Movers For August 1, 2023
Benzinga Insights
Friday, July 28, 2023
Cannabis Stock Gainers And Losers From July 28, 2023
Benzinga Insights
Wednesday, July 26, 2023
Cannabis Stock Gainers And Losers From July 26, 2023
Benzinga Insights
Thursday, July 20, 2023
Cannabis Stock Movers For July 20, 2023
Benzinga Insights
Jeeter Enters Hemp-Derived CBD Market Via Lifted Made
Vuk Zdinjak
Monday, May 15, 2023
LFTD Partners Inc. Reports Q1 2023 Earnings, 31% Revenue Decrease YoY, How About Net Loss?
Joana Scopel
Monday, March 27, 2023
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Lara Goldstein
Wednesday, March 22, 2023
LFTD Partners 2022 Revenue Grows 81% To $57.42M
Vuk Zdinjak
Friday, January 13, 2023
Lifted Made Teams Up With Cali Sweets To Manufacture And Distribute Its Disposable Vape And Gummy Products
Vuk Zdinjak
Tuesday, January 03, 2023
Lifted Made To Recoup $1M Of The Losses From Clogged Disposable Vape Devices
Vuk Zdinjak
Monday, November 14, 2022
LFTD Partners Q3 Revenue Grows 27% YoY To $11.2M
Vuk Zdinjak
Friday, August 12, 2022
Despite Strong Income And Revenue Growth LFTD Stock Plunges Following Earnings Release
Vuk Zdinjak
Tuesday, July 26, 2022
LFTD Partners Prepays Its Remaining Secured Debt Of $916K
Vuk Zdinjak
Monday, July 11, 2022
LFTD Partners Lowers Its Secured Debt, Here Are The Details
Vuk Zdinjak
Wednesday, June 08, 2022
LFTD Partners Inc. Prepays One Third Of Total Secured Debt With Free Cash Flow From Subsidiary Company Lifted Made
Lara Goldstein
Tuesday, May 17, 2022
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
Natan Ponieman
Thursday, May 12, 2022
LFTD Partners Inc Revenue Up 41% From Previous Quarter, Shares Financial Results For Q1 2022
Fermin Orgambide
Wednesday, April 06, 2022
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
Natan Ponieman
Friday, April 01, 2022
LFTD Partners Posts Record Revenue For 2021 With Hemp-Derived Cannabinoid Products And Other Offerings
Natan Ponieman
